Sign in

CIK 0001735438 · Non-accelerated filer<br>Smaller reporting company

MeiraGTx Holdings plc

Sign in to watch
Ticker
MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
981448305
Phone
646-860-7985
Business address
655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,710,812
in 3 filings, $1.7M under 10b5-1 plans

Net −$1,710,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-08 SHENK THOMAS E Director Grant or award · Stock Option (right to buy) +20,000 20,000
2023-06-08 SHENK THOMAS E Director Grant or award · Restricted Share Units +20,000 20,000
2023-06-08 Seligman Nicole Director Grant or award · Stock Option (right to buy) +22,500 22,500
2023-06-08 Seligman Nicole Director Grant or award · Restricted Share Units +22,500 22,500
2023-06-08 Mendoza Neil Director Grant or award · Stock Option (right to buy) +20,000 20,000
2023-06-08 Mendoza Neil Director Grant or award · Restricted Share Units +20,000 20,000
2023-06-08 Hukkelhoven Ellen Director Grant or award · Stock Option (right to buy) +20,000 20,000
2023-06-08 Hukkelhoven Ellen Director Grant or award · Restricted Share Units +20,000 20,000
2023-06-08 Indyk Martin Director Grant or award · Stock Option (right to buy) +20,000 20,000
2023-06-08 Indyk Martin Director Grant or award · Restricted Share Units +20,000 20,000
2023-06-08 Harris Keith R. Director Grant or award · Stock Option (right to buy) +30,000 30,000
2023-06-08 Harris Keith R. Director Grant or award · Restricted Share Units +30,000 30,000
2023-06-07 Indyk Martin Director Option exercise +15,000 15,000
2023-06-07 Indyk Martin Director Option exercise · Restricted Share Units −15,000 0
2023-06-07 Harris Keith R. Director Option exercise +20,000 20,000
2023-06-07 Harris Keith R. Director Option exercise · Restricted Share Units −20,000 0
2023-05-05 PERCEPTIVE ADVISORS LLC Director Purchase +4,347,826 $5.75 $25.0M 11,281,103
2023-02-21 Zeldin Robert K CHIEF MEDICAL OFFICER Grant or award · Stock Option (Right to Buy) +30,000 30,000
2023-02-21 Zeldin Robert K CHIEF MEDICAL OFFICER Grant or award · Restricted Share Units +30,000 30,000
2023-02-21 Wollin Robert J GENERAL COUNSEL AND SECRETARY Grant or award · Stock Option (Right to Buy) +45,000 45,000

Page 12 of 21 · 411 trades